Metabolomics Used To Identify The Mechanism Of Action Of An Anti-Cancer Drug

Metabolomics Used To Identify The Mechanism Of Action Of An Anti-Cancer Drug
Metabolon, Inc., the leader in metabolomics-driven biomarker discovery and analysis, today announced a new study has been published identifying the mechanism of action of the anti-cancer drug GMX1778. Co-authored by scientists at Gemin X Pharmaceuticals and Metabolon, the paper "The Small Molecule GMX1778 is a Potent Inhibitor of NAD+ Biosynthesis: Strategy for Enhanced Therapy in NAPRT1-Deficient Tumors" appears online ahead of print in Molecular and Cellular Biology.

Increase In CV Risk Factors Heralds Epidemic Of Cardiovascular Disease

Increase In CV Risk Factors Heralds Epidemic Of Cardiovascular Disease
Commenting on a study published today in Circulation (1), showing after two decades of improvement, the percentage of Americans without risk factors for heart disease was falling, Professor Guy De Backer, from the Division of Cardiology at the University of Gent, Belgium, said that with the rising levels of obesity in the US such findings could hardly be considered surprising.

Dallas Confirms Sixth Human Case Of West Nile Virus

Dallas County Health and Human Services has confirmed the county's sixth human case of West Nile virus for the 2009 season.

Dallas County Health and Human Services has confirmed the county's sixth human case of West Nile virus for the 2009 season.

Source: 

Dallas County Health Department

Complete news at...